RAPT Therapeutics, Inc.
RAPTDelisted Mar 3, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001673772
RAPT Therapeutics, Inc. was delisted on Mar 3, 2026; its insiders filed their last Form 4 on Mar 5, 2026; 106 institutions reported holding it in 13F filings for Q4 2025, worth $1.02B in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding RAPT Therapeutics, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 98 | 5 | 95 | +2 |
| Shares | 30.0M | 2.51M | 32.1M | +4.59M (+16.7%) |
| Value | $721.0M | $60.3M | $634.7M | −$26.1M (−3.9%) |
5 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held RAPT Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Deep Track Capital, LP | 1,304,940 | $25.8M | 1.13% |
| Braidwell LP | 1,000,000 | $19.8M | 0.66% |
| Walleye Capital LLC | 284,418 | $5.63M | 0.12% |
| Norges Bank | 258,200 | $5.11M | 0.00% |
| Logos Global Management LP | 200,000 | $3.96M | 0.46% |
| Integral Health Asset Management, LLC | 109,000 | $2.16M | 0.49% |
| Trustees of Columbia University in the City of New York | 73,383 | $1.45M | 2.99% |
| Cheyne Capital Management (UK) LLP | 71,828 | $1.42M | 2.51% |
| Thrivent Financial for Lutherans | 59,334 | $1.17M | 0.00% |
| Vident Investment Advisory, LLC | 40,829 | $808.4K | 0.03% |
| Man Group plc | 32,422 | $642.0K | 0.00% |
| Weiss Multi-Strategy Advisers LLC | 25,010 | $495.0K | 0.01% |
| Pentwater Capital Management LP | 25,000 | $495.0K | 0.02% |
| Two Sigma Investments, LP | 20,600 | $407.9K | 0.00% |
| Walleye Trading LLC | 12,617 | $249.8K | 0.01% |
| Telemetry Investments, L.L.C. | 12,000 | $238.0K | 0.56% |
| Mariner, LLC | 10,474 | $207.0K | 0.00% |
| Fred Alger Management, LLC | 6,169 | $122.1K | 0.00% |
| New England Capital Financial Advisors LLC | 1,000 | $28.2K | 0.02% |
Sold out (17)
Institutions that held RAPT Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Invesco Ltd. | 154,934 | $3.73M |
| Wellington Management Group LLP | 112,579 | $2.71M |
| Board of Trustees of The Leland Stanford Junior University | 81,237 | $1.98M |
| UBS Oconnor LLC | 69,812 | $1.68M |
| Gsa Capital Partners LLP | 37,891 | $912.0K |
| State Board of Administration of Florida Retirement System | 16,711 | $402.0K |
| UBS Asset Management Americas Inc | 11,982 | $288.3K |
| Voya Investment Management LLC | 9,924 | $238.8K |
| Connor, Clark & Lunn Investment Management Ltd. | 9,413 | $226.0K |
| Franklin Resources Inc | 8,675 | $209.0K |
| Ensign Peak Advisors, Inc | 6,740 | $162.0K |
| SG Americas Securities, LLC | 6,351 | $153.0K |
| Wells Fargo & Company | 769 | $19.0K |
| Aquatic Capital Management LLC | 500 | $12.0K |
| High Net Worth Advisory Group LLC | 500 | $12.0K |
| Allspring Global Investments Holdings, LLC | 57 | $1.00K |
| Lindbrook Capital, LLC | 13 | $0 |
Not filed for Q4 2022 yet (5)
Institutions that held RAPT Therapeutics, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Ponoi Management, LLC | 1,599,417 | $38.5M |
| KPCB XV Associates, LLC | 648,531 | $15.6M |
| Ponoi II Management, LLC | 145,401 | $3.50M |
| AJU IB Investment Co., Ltd. | 99,503 | $2.39M |
| Portman Ltd | 12,765 | $307.0K |